Pluronic®/casein micelles for ophthalmic delivery of resveratrol: In vitro, ex vivo, and in vivo tests

[Display omitted] •Single and mixed micelles increased 50-fold resveratrol apparent solubility, ensuring that > 99 % resveratrol was encapsulated.•Anionic casein micelles did not uptake resveratrol but promoted the encapsulation in the mixed micelles.•Resveratrol-loaded micelles were stable for 3...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2022-11, Vol.628, p.122281-122281, Article 122281
Hauptverfasser: Vivero-Lopez, Maria, Sparacino, Chiara, Quelle-Regaldie, Ana, Sánchez, Laura, Candal, Eva, Barreiro-Iglesias, Antón, Huete-Toral, Fernando, Carracedo, Gonzalo, Otero, Ana, Concheiro, Angel, Alvarez-Lorenzo, Carmen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 122281
container_issue
container_start_page 122281
container_title International journal of pharmaceutics
container_volume 628
creator Vivero-Lopez, Maria
Sparacino, Chiara
Quelle-Regaldie, Ana
Sánchez, Laura
Candal, Eva
Barreiro-Iglesias, Antón
Huete-Toral, Fernando
Carracedo, Gonzalo
Otero, Ana
Concheiro, Angel
Alvarez-Lorenzo, Carmen
description [Display omitted] •Single and mixed micelles increased 50-fold resveratrol apparent solubility, ensuring that > 99 % resveratrol was encapsulated.•Anionic casein micelles did not uptake resveratrol but promoted the encapsulation in the mixed micelles.•Resveratrol-loaded micelles were stable for 30 days at 4 °C, withstood strong dilution, and showed sol–gel transition.•Single and mixed micelles showed zebrafish embryo compatibility and antioxidant and antimicrobial properties.•All micelles favored resveratrol accumulation in cornea and sclera ex vivo, as confirmed in vivo for single micelles. Ocular health may strongly benefit from the supply of antioxidant agents that counteract free radicals and reactive oxygen species responsible for long-term eye diseases. Additionally, natural antioxidants like resveratrol can inhibit bacteria growth and restore natural microbiota. However, their use is hindered by limited solubility, fast degradation, and low ocular permeability. This work aimed to overcome these limitations by preparing single and mixed micelles of Pluronic® F127 and casein that serve as resveratrol nanocarriers. Single and mixed (0.1 % casein) micelles (0.0 to −17.0 mV; 2.4 to 32.7 nm) increased 50-fold resveratrol solubility, remained stable for one month at 4 °C, withstood fast dilution, underwent sol-to-gel transitions in the 23.9–27.1 °C range, and exhibited potent antioxidant properties. All formulations successfully passed the HET-CAM assay but showed Pluronic®-casein dose-dependent toxicity in the zebrafish embryo model. Resveratrol-loaded single and mixed micelles (10–15 mM Pluronic® F127) displayed antimicrobial activity against S. aureus and P. aeruginosa. The micelles favored resveratrol accumulation in cornea and sclera, but mixed micelles showed larger lag times and provided lower amount of resveratrol permeated through sclera. In vivo (rabbit) tests confirmed the safety of resveratrol-loaded single micelles and their capability to supply resveratrol to anterior and posterior eye segments.
doi_str_mv 10.1016/j.ijpharm.2022.122281
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2725191000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517322008365</els_id><sourcerecordid>2725191000</sourcerecordid><originalsourceid>FETCH-LOGICAL-c319t-f87cc31d7b0a017e2d2a1fc4db51dd81c8ddb8af1f349a0677968a7868b6b46a3</originalsourceid><addsrcrecordid>eNqFkE1OAzEMhSMEEqVwBKQsWTBtnPlJygYhxE-lSrCAdZRJPDTVdFKSaUUvxSE4GSntnpU_W8-23iPkEtgIGFTjxcgtVnMdliPOOB8B51zCERmAFHmWF6I6JgOWC5mVIPJTchbjgjFWccgH5OO1XQffOfPzPTY6ouvo0hlsW4y08YH61byf6zbNqMXWbTBsqW9owJhQ98G3N3Ta0Y1LeE3xK9Emge4sdd1fQ3uMfTwnJ41uI14c6pC8Pz683T9ns5en6f3dLDM5TPqskcIksqJmmoFAbrmGxhS2LsFaCUZaW0vdQJMXE80qISaV1EJWsq7qotL5kFzt766C_1ynz2rp4s6P7tCvo-KClzCB5D9Jy73UBB9jwEatglvqsFXA1C5YtVCHYNUuWLUPNu3d7vcw-dg4DCoah51B6wKaXlnv_rnwCyB2hjI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2725191000</pqid></control><display><type>article</type><title>Pluronic®/casein micelles for ophthalmic delivery of resveratrol: In vitro, ex vivo, and in vivo tests</title><source>Elsevier ScienceDirect Journals</source><creator>Vivero-Lopez, Maria ; Sparacino, Chiara ; Quelle-Regaldie, Ana ; Sánchez, Laura ; Candal, Eva ; Barreiro-Iglesias, Antón ; Huete-Toral, Fernando ; Carracedo, Gonzalo ; Otero, Ana ; Concheiro, Angel ; Alvarez-Lorenzo, Carmen</creator><creatorcontrib>Vivero-Lopez, Maria ; Sparacino, Chiara ; Quelle-Regaldie, Ana ; Sánchez, Laura ; Candal, Eva ; Barreiro-Iglesias, Antón ; Huete-Toral, Fernando ; Carracedo, Gonzalo ; Otero, Ana ; Concheiro, Angel ; Alvarez-Lorenzo, Carmen</creatorcontrib><description>[Display omitted] •Single and mixed micelles increased 50-fold resveratrol apparent solubility, ensuring that &gt; 99 % resveratrol was encapsulated.•Anionic casein micelles did not uptake resveratrol but promoted the encapsulation in the mixed micelles.•Resveratrol-loaded micelles were stable for 30 days at 4 °C, withstood strong dilution, and showed sol–gel transition.•Single and mixed micelles showed zebrafish embryo compatibility and antioxidant and antimicrobial properties.•All micelles favored resveratrol accumulation in cornea and sclera ex vivo, as confirmed in vivo for single micelles. Ocular health may strongly benefit from the supply of antioxidant agents that counteract free radicals and reactive oxygen species responsible for long-term eye diseases. Additionally, natural antioxidants like resveratrol can inhibit bacteria growth and restore natural microbiota. However, their use is hindered by limited solubility, fast degradation, and low ocular permeability. This work aimed to overcome these limitations by preparing single and mixed micelles of Pluronic® F127 and casein that serve as resveratrol nanocarriers. Single and mixed (0.1 % casein) micelles (0.0 to −17.0 mV; 2.4 to 32.7 nm) increased 50-fold resveratrol solubility, remained stable for one month at 4 °C, withstood fast dilution, underwent sol-to-gel transitions in the 23.9–27.1 °C range, and exhibited potent antioxidant properties. All formulations successfully passed the HET-CAM assay but showed Pluronic®-casein dose-dependent toxicity in the zebrafish embryo model. Resveratrol-loaded single and mixed micelles (10–15 mM Pluronic® F127) displayed antimicrobial activity against S. aureus and P. aeruginosa. The micelles favored resveratrol accumulation in cornea and sclera, but mixed micelles showed larger lag times and provided lower amount of resveratrol permeated through sclera. In vivo (rabbit) tests confirmed the safety of resveratrol-loaded single micelles and their capability to supply resveratrol to anterior and posterior eye segments.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2022.122281</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>In vivo tear fluid levels ; Mixed micelles ; Ocular biodistribution ; Pluronic® F127 ; Resveratrol ; Zebrafish</subject><ispartof>International journal of pharmaceutics, 2022-11, Vol.628, p.122281-122281, Article 122281</ispartof><rights>2022 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c319t-f87cc31d7b0a017e2d2a1fc4db51dd81c8ddb8af1f349a0677968a7868b6b46a3</citedby><cites>FETCH-LOGICAL-c319t-f87cc31d7b0a017e2d2a1fc4db51dd81c8ddb8af1f349a0677968a7868b6b46a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0378517322008365$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Vivero-Lopez, Maria</creatorcontrib><creatorcontrib>Sparacino, Chiara</creatorcontrib><creatorcontrib>Quelle-Regaldie, Ana</creatorcontrib><creatorcontrib>Sánchez, Laura</creatorcontrib><creatorcontrib>Candal, Eva</creatorcontrib><creatorcontrib>Barreiro-Iglesias, Antón</creatorcontrib><creatorcontrib>Huete-Toral, Fernando</creatorcontrib><creatorcontrib>Carracedo, Gonzalo</creatorcontrib><creatorcontrib>Otero, Ana</creatorcontrib><creatorcontrib>Concheiro, Angel</creatorcontrib><creatorcontrib>Alvarez-Lorenzo, Carmen</creatorcontrib><title>Pluronic®/casein micelles for ophthalmic delivery of resveratrol: In vitro, ex vivo, and in vivo tests</title><title>International journal of pharmaceutics</title><description>[Display omitted] •Single and mixed micelles increased 50-fold resveratrol apparent solubility, ensuring that &gt; 99 % resveratrol was encapsulated.•Anionic casein micelles did not uptake resveratrol but promoted the encapsulation in the mixed micelles.•Resveratrol-loaded micelles were stable for 30 days at 4 °C, withstood strong dilution, and showed sol–gel transition.•Single and mixed micelles showed zebrafish embryo compatibility and antioxidant and antimicrobial properties.•All micelles favored resveratrol accumulation in cornea and sclera ex vivo, as confirmed in vivo for single micelles. Ocular health may strongly benefit from the supply of antioxidant agents that counteract free radicals and reactive oxygen species responsible for long-term eye diseases. Additionally, natural antioxidants like resveratrol can inhibit bacteria growth and restore natural microbiota. However, their use is hindered by limited solubility, fast degradation, and low ocular permeability. This work aimed to overcome these limitations by preparing single and mixed micelles of Pluronic® F127 and casein that serve as resveratrol nanocarriers. Single and mixed (0.1 % casein) micelles (0.0 to −17.0 mV; 2.4 to 32.7 nm) increased 50-fold resveratrol solubility, remained stable for one month at 4 °C, withstood fast dilution, underwent sol-to-gel transitions in the 23.9–27.1 °C range, and exhibited potent antioxidant properties. All formulations successfully passed the HET-CAM assay but showed Pluronic®-casein dose-dependent toxicity in the zebrafish embryo model. Resveratrol-loaded single and mixed micelles (10–15 mM Pluronic® F127) displayed antimicrobial activity against S. aureus and P. aeruginosa. The micelles favored resveratrol accumulation in cornea and sclera, but mixed micelles showed larger lag times and provided lower amount of resveratrol permeated through sclera. In vivo (rabbit) tests confirmed the safety of resveratrol-loaded single micelles and their capability to supply resveratrol to anterior and posterior eye segments.</description><subject>In vivo tear fluid levels</subject><subject>Mixed micelles</subject><subject>Ocular biodistribution</subject><subject>Pluronic® F127</subject><subject>Resveratrol</subject><subject>Zebrafish</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkE1OAzEMhSMEEqVwBKQsWTBtnPlJygYhxE-lSrCAdZRJPDTVdFKSaUUvxSE4GSntnpU_W8-23iPkEtgIGFTjxcgtVnMdliPOOB8B51zCERmAFHmWF6I6JgOWC5mVIPJTchbjgjFWccgH5OO1XQffOfPzPTY6ouvo0hlsW4y08YH61byf6zbNqMXWbTBsqW9owJhQ98G3N3Ta0Y1LeE3xK9Emge4sdd1fQ3uMfTwnJ41uI14c6pC8Pz683T9ns5en6f3dLDM5TPqskcIksqJmmoFAbrmGxhS2LsFaCUZaW0vdQJMXE80qISaV1EJWsq7qotL5kFzt766C_1ynz2rp4s6P7tCvo-KClzCB5D9Jy73UBB9jwEatglvqsFXA1C5YtVCHYNUuWLUPNu3d7vcw-dg4DCoah51B6wKaXlnv_rnwCyB2hjI</recordid><startdate>20221125</startdate><enddate>20221125</enddate><creator>Vivero-Lopez, Maria</creator><creator>Sparacino, Chiara</creator><creator>Quelle-Regaldie, Ana</creator><creator>Sánchez, Laura</creator><creator>Candal, Eva</creator><creator>Barreiro-Iglesias, Antón</creator><creator>Huete-Toral, Fernando</creator><creator>Carracedo, Gonzalo</creator><creator>Otero, Ana</creator><creator>Concheiro, Angel</creator><creator>Alvarez-Lorenzo, Carmen</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20221125</creationdate><title>Pluronic®/casein micelles for ophthalmic delivery of resveratrol: In vitro, ex vivo, and in vivo tests</title><author>Vivero-Lopez, Maria ; Sparacino, Chiara ; Quelle-Regaldie, Ana ; Sánchez, Laura ; Candal, Eva ; Barreiro-Iglesias, Antón ; Huete-Toral, Fernando ; Carracedo, Gonzalo ; Otero, Ana ; Concheiro, Angel ; Alvarez-Lorenzo, Carmen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c319t-f87cc31d7b0a017e2d2a1fc4db51dd81c8ddb8af1f349a0677968a7868b6b46a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>In vivo tear fluid levels</topic><topic>Mixed micelles</topic><topic>Ocular biodistribution</topic><topic>Pluronic® F127</topic><topic>Resveratrol</topic><topic>Zebrafish</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vivero-Lopez, Maria</creatorcontrib><creatorcontrib>Sparacino, Chiara</creatorcontrib><creatorcontrib>Quelle-Regaldie, Ana</creatorcontrib><creatorcontrib>Sánchez, Laura</creatorcontrib><creatorcontrib>Candal, Eva</creatorcontrib><creatorcontrib>Barreiro-Iglesias, Antón</creatorcontrib><creatorcontrib>Huete-Toral, Fernando</creatorcontrib><creatorcontrib>Carracedo, Gonzalo</creatorcontrib><creatorcontrib>Otero, Ana</creatorcontrib><creatorcontrib>Concheiro, Angel</creatorcontrib><creatorcontrib>Alvarez-Lorenzo, Carmen</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vivero-Lopez, Maria</au><au>Sparacino, Chiara</au><au>Quelle-Regaldie, Ana</au><au>Sánchez, Laura</au><au>Candal, Eva</au><au>Barreiro-Iglesias, Antón</au><au>Huete-Toral, Fernando</au><au>Carracedo, Gonzalo</au><au>Otero, Ana</au><au>Concheiro, Angel</au><au>Alvarez-Lorenzo, Carmen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pluronic®/casein micelles for ophthalmic delivery of resveratrol: In vitro, ex vivo, and in vivo tests</atitle><jtitle>International journal of pharmaceutics</jtitle><date>2022-11-25</date><risdate>2022</risdate><volume>628</volume><spage>122281</spage><epage>122281</epage><pages>122281-122281</pages><artnum>122281</artnum><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>[Display omitted] •Single and mixed micelles increased 50-fold resveratrol apparent solubility, ensuring that &gt; 99 % resveratrol was encapsulated.•Anionic casein micelles did not uptake resveratrol but promoted the encapsulation in the mixed micelles.•Resveratrol-loaded micelles were stable for 30 days at 4 °C, withstood strong dilution, and showed sol–gel transition.•Single and mixed micelles showed zebrafish embryo compatibility and antioxidant and antimicrobial properties.•All micelles favored resveratrol accumulation in cornea and sclera ex vivo, as confirmed in vivo for single micelles. Ocular health may strongly benefit from the supply of antioxidant agents that counteract free radicals and reactive oxygen species responsible for long-term eye diseases. Additionally, natural antioxidants like resveratrol can inhibit bacteria growth and restore natural microbiota. However, their use is hindered by limited solubility, fast degradation, and low ocular permeability. This work aimed to overcome these limitations by preparing single and mixed micelles of Pluronic® F127 and casein that serve as resveratrol nanocarriers. Single and mixed (0.1 % casein) micelles (0.0 to −17.0 mV; 2.4 to 32.7 nm) increased 50-fold resveratrol solubility, remained stable for one month at 4 °C, withstood fast dilution, underwent sol-to-gel transitions in the 23.9–27.1 °C range, and exhibited potent antioxidant properties. All formulations successfully passed the HET-CAM assay but showed Pluronic®-casein dose-dependent toxicity in the zebrafish embryo model. Resveratrol-loaded single and mixed micelles (10–15 mM Pluronic® F127) displayed antimicrobial activity against S. aureus and P. aeruginosa. The micelles favored resveratrol accumulation in cornea and sclera, but mixed micelles showed larger lag times and provided lower amount of resveratrol permeated through sclera. In vivo (rabbit) tests confirmed the safety of resveratrol-loaded single micelles and their capability to supply resveratrol to anterior and posterior eye segments.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.ijpharm.2022.122281</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2022-11, Vol.628, p.122281-122281, Article 122281
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_2725191000
source Elsevier ScienceDirect Journals
subjects In vivo tear fluid levels
Mixed micelles
Ocular biodistribution
Pluronic® F127
Resveratrol
Zebrafish
title Pluronic®/casein micelles for ophthalmic delivery of resveratrol: In vitro, ex vivo, and in vivo tests
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T04%3A33%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pluronic%C2%AE/casein%20micelles%20for%20ophthalmic%20delivery%20of%20resveratrol:%20In%20vitro,%20ex%20vivo,%20and%20in%20vivo%20tests&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Vivero-Lopez,%20Maria&rft.date=2022-11-25&rft.volume=628&rft.spage=122281&rft.epage=122281&rft.pages=122281-122281&rft.artnum=122281&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2022.122281&rft_dat=%3Cproquest_cross%3E2725191000%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2725191000&rft_id=info:pmid/&rft_els_id=S0378517322008365&rfr_iscdi=true